157 related articles for article (PubMed ID: 30251155)
1. Identification and characterization of in vivo, in vitro and reactive metabolites of vandetanib using LC-ESI-MS/MS.
Attwa MW; Kadi AA; Darwish HW; Amer SM; Al-Shakliah NS
Chem Cent J; 2018 Sep; 12(1):99. PubMed ID: 30251155
[TBL] [Abstract][Full Text] [Related]
2. Profiling of
Al-Shakliah NS; Kadi AA; Aljohar HI; AlRabiah H; Attwa MW
RSC Adv; 2022 Jul; 12(32):20991-21003. PubMed ID: 35919181
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of
Al-Shakliah NS; Attwa MW; Kadi AA; AlRabiah H
RSC Adv; 2020 Apr; 10(28):16231-16244. PubMed ID: 35498820
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of
Al-Shakliah NS; Attwa MW; AlRabiah H; Kadi AA
Anal Methods; 2021 Jan; 13(3):399-410. PubMed ID: 33410830
[TBL] [Abstract][Full Text] [Related]
5. Characterization of in vivo metabolites in rat urine following an oral dose of masitinib by liquid chromatography tandem mass spectrometry.
Kadi AA; Amer SM; Darwish HW; Attwa MW
Chem Cent J; 2018 May; 12(1):61. PubMed ID: 29766296
[TBL] [Abstract][Full Text] [Related]
6. LC-ESI-MS/MS identification and characterization of ponatinib in vivo phase I and phase II metabolites.
Attwa MW; Kadi AA; Darwish HW; Amer SM; AlRabiah H
Clin Chim Acta; 2018 Oct; 485():144-151. PubMed ID: 29966620
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro metabolism and pharmacokinetics of cholinesterase inhibitor deoxyvasicine from aerial parts of Peganum harmala Linn in rats via UPLC-ESI-QTOF-MS and UPLC-ESI-MS/MS.
Deng G; Liu W; Ma C; Rong X; Zhang Y; Wang Y; Wu C; Cao N; Ding W; Guan H; Cheng X; Wang C
J Ethnopharmacol; 2019 May; 236():288-301. PubMed ID: 30872168
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/MS reveals the formation of iminium and quinone methide reactive intermediates in entrectinib metabolism: In vivo and in vitro metabolic investigation.
Attwa MW; Kadi AA; Alrabiah H; Darwish HW
J Pharm Biomed Anal; 2018 Oct; 160():19-30. PubMed ID: 30055343
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of vilazodone metabolites in rats and microsomes by ultrahigh-performance liquid chromatography/quadrupole time-of-flight tandem mass spectrometry.
Chavan BB; Kalariya PD; Tiwari S; Nimbalkar RD; Garg P; Srinivas R; Talluri MVNK
Rapid Commun Mass Spectrom; 2017 Dec; 31(23):1974-1984. PubMed ID: 28875544
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography tandem mass spectrometry method for the quantification of vandetanib in human plasma and rat liver microsomes matrices: metabolic stability investigation.
Amer SM; Kadi AA; Darwish HW; Attwa MW
Chem Cent J; 2017 May; 11(1):45. PubMed ID: 29086823
[TBL] [Abstract][Full Text] [Related]
11. LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways.
Kadi AA; Attwa MW; Darwish HW
RSC Adv; 2018 Jan; 8(3):1182-1190. PubMed ID: 35540908
[TBL] [Abstract][Full Text] [Related]
12. Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC-MS/MS:
Kadi AA; Darwish HW; Abuelizz HA; Alsubi TA; Attwa MW
R Soc Open Sci; 2019 Jan; 6(1):181714. PubMed ID: 30800400
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Fenebrutinib Metabolism and Bioactivation Using MS
Alsibaee AM; Aljohar HI; Attwa MW; Abdelhameed AS; Kadi AA
Molecules; 2023 May; 28(10):. PubMed ID: 37241965
[TBL] [Abstract][Full Text] [Related]
14. Identification and structural characterization of in vivo metabolites of balofloxacin in rat plasma, urine and feces samples using Q-TOF/LC/ESI/MS/MS : In silico toxicity studies.
Shankar G; Borkar RM; Udutha S; Anagoni SP; Srinivas R
J Pharm Biomed Anal; 2018 Sep; 159():200-211. PubMed ID: 29990887
[TBL] [Abstract][Full Text] [Related]
15. In vivo metabolic investigation of moxifloxacin using liquid chromatography/electrospray ionization tandem mass spectrometry in combination with online hydrogen/deuterium exchange experiments.
Raju B; Ramesh M; Borkar RM; Srinivas R; Padiya R; Banerjee SK
Rapid Commun Mass Spectrom; 2012 Aug; 26(16):1817-31. PubMed ID: 22777784
[TBL] [Abstract][Full Text] [Related]
16. Sapitinib: reactive intermediates and bioactivation pathways characterized by LC-MS/MS.
Attwa MW; Kadi AA
RSC Adv; 2019 Oct; 9(57):32995-33006. PubMed ID: 35529145
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach.
Abdelhameed AS; Attwa MW; Kadi AA
Drug Des Devel Ther; 2020; 14():5259-5273. PubMed ID: 33299299
[TBL] [Abstract][Full Text] [Related]
18. LC-MS/MS reveals the formation of reactive ortho-quinone and iminium intermediates in saracatinib metabolism: Phase I metabolic profiling.
Attwa MW; Kadi AA; Darwish HW; Alrabiah H
Clin Chim Acta; 2018 Jul; 482():84-94. PubMed ID: 29614307
[TBL] [Abstract][Full Text] [Related]
19. Piperazine ring toxicity in three novel anti-breast cancer drugs: an in silico and in vitro metabolic bioactivation approach using olaparib as a case study.
Alsubi TA; Attwa MW; Darwish HW; Abuelizz HA; Kadi AA
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1435-1450. PubMed ID: 36738368
[TBL] [Abstract][Full Text] [Related]
20. Identification of Iminium Intermediates Generation in the Metabolism of Tepotinib Using LC-MS/MS: In Silico and Practical Approaches to Bioactivation Pathway Elucidation.
Abdelhameed AS; Attwa MW; Kadi AA
Molecules; 2020 Oct; 25(21):. PubMed ID: 33126762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
